Physician
NG, Frederick
NG, Frederick was paid $1.65M by Medicaid between Jan 2018 and Oct 2024, across 120 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 9.8% of everything it billed.
33Billing provider infoNG, FREDERICK
HOFFMAN ESTATES, IL 60194
HOFFMAN ESTATES, IL 60194
33aNPI1215938097assigned 08/03/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.65M
24GClaims258,497
24DCodes billed120
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#48 of 398
Median peer was paid$66K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 220 | $6K | |
| 2019 | 399 | $12K | |
| 2020 | 685 | $23K | |
| 2021 | 16,110 | $144K | |
| 2022 | 100,239 | $634K | |
| 2023 | 100,013 | $618K | |
| 2024incomplete | 40,831 | $209K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 9.8% | 31,141 | 21,705 | $161K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.8% | 2,934 | 2,318 | $112K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.4% | 36,032 | 23,410 | $105K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.1% | 4,172 | 3,592 | $100K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5.8% | 720 | 703 | $96K |
| 88307 | 5.2% | 1,394 | 1,156 | $86K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.5% | 3,346 | 3,248 | $75K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.1% | 1,866 | 1,708 | $67K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.2% | 526 | 486 | $36K |
| 87040 | 2.1% | 3,870 | 3,079 | $35K | |
| 82947 | 2.1% | 7,812 | 3,303 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.0% | 7,748 | 3,927 | $33K |
108 more codes
| 87641 | 1.9% | 1,386 | $31K | |
| 84484 | 1.7% | 6,329 | $28K | |
| 85027 | 1.7% | 9,447 | $27K | |
| 83735 | 1.7% | 7,436 | $27K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.6% | 1,148 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 1,139 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 2,863 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 700 | $23K |
| 84703 | 1.2% | 5,553 | $20K | |
| 83880 | 1.2% | 1,669 | $20K | |
| 86850 | 1.2% | 6,404 | $19K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 3,749 | $19K |
| 86901 | 1.2% | 8,564 | $19K | |
| 82805 | 1.1% | 668 | $18K | |
| 81001 | 1.1% | 12,272 | $18K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.0% | 1,908 | $17K |
| 83690 | 1.0% | 5,049 | $17K | |
| 80061 | Lipid panel | <1% | 3,886 | $16K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 90 | $15K |
| 86900 | <1% | 8,568 | $15K | |
| 86003 | <1% | 361 | $14K | |
| 85730 | <1% | 3,699 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,522 | $11K |
| 87186 | <1% | 1,645 | $11K | |
| 83605 | <1% | 2,054 | $11K | |
| 86140 | <1% | 4,134 | $10K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 211 | $9K |
| 84439 | <1% | 2,051 | $9K | |
| 85610 | <1% | 4,313 | $9K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 155 | $8K |
| 88342 | <1% | 495 | $8K | |
| 81025 | <1% | 3,217 | $8K | |
| 84030 | <1% | 2,874 | $8K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 30 | $7K |
| 82803 | <1% | 701 | $7K | |
| 85379 | <1% | 1,780 | $7K | |
| 82247 | <1% | 2,860 | $7K | |
| 84100 | <1% | 3,003 | $7K | |
| 82607 | <1% | 1,027 | $6K | |
| 82810 | <1% | 1,156 | $6K | |
| 84702 | <1% | 1,252 | $6K | |
| 83655 | <1% | 931 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 144 | $5K |
| 86880 | <1% | 1,526 | $5K | |
| 87806 | <1% | 437 | $4K | |
| 82248 | <1% | 1,947 | $4K | |
| 80069 | <1% | 978 | $4K | |
| 82570 | <1% | 1,644 | $4K | |
| 82746 | <1% | 629 | $4K | |
| 82728 | <1% | 825 | $3K | |
| 86920 | <1% | 747 | $3K | |
| 83550 | <1% | 760 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 60 | $3K |
| 82550 | <1% | 984 | $3K | |
| 85384 | <1% | 904 | $3K | |
| 87070 | <1% | 852 | $3K | |
| 83540 | <1% | 846 | $3K | |
| 88304 | <1% | 141 | $3K | |
| 87210 | <1% | 977 | $2K | |
| 82330 | <1% | 252 | $2K | |
| 87486 | <1% | 90 | $2K | |
| 87581 | <1% | 90 | $2K | |
| 86592 | <1% | 969 | $2K | |
| 85652 | <1% | 1,398 | $2K | |
| 87205 | <1% | 983 | $2K | |
| 81003 | <1% | 1,642 | $2K | |
| 84156 | <1% | 1,339 | $2K | |
| 84550 | <1% | 764 | $2K | |
| 82951 | <1% | 214 | $1K | |
| 82077 | <1% | 106 | $1K | |
| 80164 | <1% | 241 | $1K | |
| 87449 | <1% | 127 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 47 | $1K |
| 83970 | <1% | 69 | $1K | |
| 84132 | <1% | 408 | $813.61 | |
| 87340 | <1% | 126 | $805.83 | |
| 86039 | <1% | 149 | $788.82 | |
| 82140 | <1% | 174 | $772.70 | |
| 82784 | <1% | 123 | $737.68 | |
| 86480 | <1% | 27 | $701.19 | |
| 85018 | <1% | 569 | $666.08 | |
| 85014 | <1% | 499 | $582.32 | |
| 80076 | <1% | 150 | $577.11 | |
| 83615 | <1% | 176 | $491.25 | |
| 84481 | <1% | 80 | $424.27 | |
| 86308 | <1% | 174 | $417.60 | |
| 85045 | <1% | 315 | $398.23 | |
| 82952 | <1% | 200 | $382.00 | |
| 86870 | <1% | 47 | $358.50 | |
| 87081 | <1% | 112 | $324.80 | |
| 84145 | <1% | 15 | $303.87 | |
| 80202 | <1% | 42 | $285.52 | |
| 82533 | <1% | 33 | $234.85 | |
| 84300 | <1% | 85 | $189.84 | |
| 87045 | <1% | 30 | $181.35 | |
| 82565 | <1% | 78 | $176.09 | |
| 84403 | <1% | 12 | $164.32 | |
| 84478 | <1% | 66 | $162.07 | |
| 80179 | <1% | 13 | $145.34 | |
| 87420 | <1% | 17 | $133.45 | |
| 84402 | <1% | 12 | $110.04 | |
| 82043 | <1% | 54 | $107.43 | |
| 84436 | <1% | 26 | $85.07 | |
| 87088 | <1% | 12 | $73.45 | |
| 82009 | <1% | 39 | $55.64 | |
| 84295 | <1% | 15 | $44.27 | |
| 82435 | <1% | 15 | $38.26 | |
| 86001 | <1% | 12 | $32.64 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.